glycoengineering
Analyze and engineer protein glycosylation. Scan sequences for N-glycosylation sequons (N-X-S/T), predict O-glycosylation hotspots, and access curated glycoengineering tools (NetOGlyc, GlycoShield, GlycoWorkbench). For glycoprotein engineering, therapeutic antibody optimization, and vaccine design.
By k-dense-ai · 1,387 installs
npx skills add k-dense-ai/scientific-agent-skills --skill glycoengineering
Source repository · Upstream listing
Glycoengineering
Overview
Glycosylation is the most common and complex post translational modification (PTM) of proteins, affecting over 50% of all human proteins. Glycans regulate protein folding, stability, immune recognition, receptor interactions, and pharmacokinetics of therapeutic proteins. Glycoengineering involves rational modification of glycosylation patterns for improved therapeutic efficacy, stability, or immune evasion.
Two major glycosylation types:
N glycosylation : Attached to asparagine (N) in the sequon N X [S/T] where X ≠ Proline; occurs in the ER/Golgi
O glycosylation : Attached to serine (S) or threonine (T); no strict consensus motif; primarily GalNAc initiation
When to Use This Skill
Use this skill when:
Antibody engineering : Optimize Fc glycosylation for enhanced ADCC, CDC, or reduced immunogenicity
Therapeutic protein design : Identify glycosylation sites that affect half life, stability, or immunogenicity
Vaccine antigen design : Engineer glycan shields to focus immune responses on conserved epitopes
Biosimilar characterization : Compare glycan patterns between reference and biosimilar
Drug target analysis : Does glycosylation affect target engagement for a receptor?
Protein stability : N glycans often stabilize proteins; identify sites for stabilizing mutations
N Glycosylation Sequon Analysis
Scanning for N Glycosylation Sites
N glycosylation occurs at the sequon N X [S/T] where X ≠ Proline.
Mutating N Glycosylation Sites
O Glycosylation Analysis
Heuristic O Glycosylation Hotspot Prediction
External Glycoengineering Tools
1. NetOGlyc 4.0 (O glycosylation prediction)
Web service for high accuracy O GalNAc site prediction:
URL : https://services.healthtech.dtu.dk/services/NetOGlyc 4.0/
Input : FASTA protein sequence
Output : Per residue O glycosylation probability scores
Method : Neural network trained on experimentally verified O GalNAc sites
2. GlycoSHIELD (Glycan Shielding Analysis)
GlycoSHIELD grafts libraries of pre simulated glycan conformers onto a static protein structure and
scores how much of the protein surface the glycans shield, without running new MD
(Tsai et al., Cell 2024, doi:10.1016/j.cell.2024.01.034):
URL : https://gitlab.mpcdf.mpg.de/dioscuri biophysics/glycoshield md/ (web app: https://glycoshield.eu)
Use : Model the glycan shield on a glycoprotein and map per residue shielding
Output : Glycosylated PDB/XTC ensembles per site, per residue shielding plot, PDB with shielding in the B factor column
GlycoSHIELD is not on PyPI — uv pip install glycoshield fails. It ships as three scripts on top
of a small glycoshield package (needs numpy, scipy, matplotlib, MDAnalysis; GlycoSASA.py also needs
gmx from GROMACS on PATH ). Install from the checkout:
Illustrative: the flags come from the scripts' argparse definitions and the upstream tutorial
(N cadherin EC5 with Man5 glycans); they were not run here. mode CG checks clashes against
Cα atoms only and pairs with threshold 3.5 ; mode All with threshold 0.7 is the all atom
setting.
3. GlycoWorkbench (Glycan Structure Drawing/Analysis)
URL : https://www.eurocarbdb.org/project/glycoworkbench
Use : Draw glycan structures, calculate masses, annotate MS spectra
Format : GlycoCT, IUPAC condensed glycan notation
4. GlyConnect (Glycan Protein Database)
URL : https://glyconnect.expasy.org/
Use : Find experimentally verified glycoproteins and glycosylation sites
Query : By protein (UniProt ID), glycan structure, or tissue
5. UniCarbKB (Glycan Structure Database)
URL : https://unicarbkb.org/
Use : Browse glycan structures, search by mass or composition
Format : GlycoCT or IUPAC notation
Key Glycoengineering Strategies
For Therapeutic Antibodies
Goal Strategy Notes
Enhance ADCC Defucosylation at Fc Asn297 Afucosylated IgG1 has ~50× better FcγRIIIa binding
Reduce immunogenicity Remove non human glycans Eliminate α Gal, NGNA epitopes
Improve PK half life Sialylation Sialylated glycans extend half life
Reduce inflammation Hypersialylation IVIG anti inflammatory mechanism
Create glycan shield Add N glycosites to surface Masks vulnerable epitopes (vaccine design)
Common Mutations Used
Mutation Effect
N297A/Q (IgG1) Removes Fc glycosylation (aglycosyl)
N297D (IgG1) Removes Fc glycosylation
S298A/E333A/K334A Increases FcγRIIIa binding
F243L (IgG1) Increases defucosylation
T299A Removes Fc glycosylation
Glycan Notation
IUPAC Condensed Notation (Monosaccharide abbreviations)
Symbol Full Name Type
Glc Glucose Hexose
GlcNAc N Acetylglucosamine HexNAc
Man Mannose Hexose
Gal Galactose Hexose
Fuc Fucose Deoxyhexose
Neu5Ac N Acetylneuraminic acid (Sialic acid) Sialic acid
GalNAc N Acetylgalactosamine HexNAc
Complex N Glycan Structure
Best Practices
Start with NetNGlyc/NetOGlyc for computational prediction before experimental validation
Verify with mass spectrometry : Glycoproteomics (Byonic, Mascot) for site specific glycan profiling
Consider site context : Not all predicted sequons are actually glycosylated (accessibility, cell type, protein conformation)
For antibodies : Fc N297 glycan is critical — always characterize this site first
Use GlyConnect to check if your protein of interest has experimentally verified glycosylation data
Additional Resources
GlyTouCan (glycan structure repository): https://glytoucan.org/
GlyConnect : https://glyconnect.expasy.org/
CFG Functional Glycomics : http://www.functionalglycomics.org/
DTU Health Tech servers (NetNGlyc, NetOGlyc): https://services.healthtech.dtu.dk/
GlycoWorkbench : https://glycoworkbench.software.informer.com/
Review : Apweiler R et al. (1999) Biochim Biophys Acta. PMID: 10564035
Therapeutic glycoengineering review : Jefferis R (2009) Nature Reviews Drug Discovery. PMID: 19448661